Skip to content
Insider tapeFilings through Fri, Oct 2

Michael J. Farrell

CEO at Resmed Inc (RMD); CEO, Chair at Resmed Inc (RMD)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $15.7M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 10SEC RMDResmed Inc Sell Plan 4,991 $222.44 $1.1M +0.2%
Aug 11SEC RMDResmed Inc Sell Plan 4,991 $205.69 $1.0M +8.3%
Jul 9SEC RMDResmed Inc Sell Plan 4,991 $218.55 $1.1M +2.0%
Jun 9SEC RMDResmed Inc Sell Plan 4,991 $193.96 $968K +14.9%
May 11SEC RMDResmed Inc Sell Plan 4,991 $207.82 $1.0M +7.2%
Apr 9SEC RMDResmed Inc Sell Plan 4,991 $225.50 $1.1M -1.2%
Mar 11SEC RMDResmed Inc Sell Plan 4,991 $251.03 $1.3M -11.2%
Feb 10SEC RMDResmed Inc Sell Plan 4,991 $273.78 $1.4M -18.6%
Jan 8SEC RMDResmed Inc Sell Plan 4,991 $248.46 $1.2M -10.3%
Dec 9SEC RMDResmed Inc Sell Plan 4,991 $251.41 $1.3M -11.4%
Nov 10SEC RMDResmed Inc Sell Plan 8,011 $249.75 $2.0M -10.8%
Oct 9SEC RMDResmed Inc Sell Plan 8,009 $282.85 $2.3M -21.2%
  • Sell

    CEO, Chair Michael J. Farrell sold $1.1M of RMD at $222.44 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Michael J. Farrell sold $1.0M of RMD at $205.69 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Michael J. Farrell sold $1.1M of RMD at $218.55 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Michael J. Farrell sold $968K of RMD at $193.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Michael J. Farrell sold $1.0M of RMD at $207.82 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Michael J. Farrell sold $1.1M of RMD at $225.50 — pre-scheduled 10b5-1 plan sale.